Global Infliximab and biosimilar Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Infliximab and biosimilar

• 1.1 Definition of Infliximab and biosimilar
• 1.2 Infliximab and biosimilar Segment by Type
  • 1.2.1 Global Infliximab and biosimilar Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Infliximab
  • 1.2.3 infliximab-dyyb
  • 1.2.4 infliximab-abda
• 1.3 Infliximab and biosimilar Segment by Applications
  • 1.3.1 Global Infliximab and biosimilar Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Crohn's Disease
  • 1.3.3 Pediatric Crohn's Disease
  • 1.3.4 Ulcerative Colitis
  • 1.3.5 Rheumatoid Arthritis
  • 1.3.6 Ankylosing Spondylitis
  • 1.3.7 Psoriatic Arthritis
  • 1.3.8 Plaque Psoriasis
• 1.4 Global Infliximab and biosimilar Overall Market
  • 1.4.1 Global Infliximab and biosimilar Revenue (2014-2025)
  • 1.4.2 Global Infliximab and biosimilar Production (2014-2025)
  • 1.4.3 North America Infliximab and biosimilar Status and Prospect (2014-2025)
  • 1.4.4 Europe Infliximab and biosimilar Status and Prospect (2014-2025)
  • 1.4.5 China Infliximab and biosimilar Status and Prospect (2014-2025)
  • 1.4.6 Japan Infliximab and biosimilar Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Infliximab and biosimilar Status and Prospect (2014-2025)
  • 1.4.8 India Infliximab and biosimilar Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Infliximab and biosimilar
• 2.3 Manufacturing Process Analysis of Infliximab and biosimilar
• 2.4 Industry Chain Structure of Infliximab and biosimilar

3 Development and Manufacturing Plants Analysis of Infliximab and biosimilar

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Infliximab and biosimilar Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Infliximab and biosimilar
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Infliximab and biosimilar Production and Capacity Analysis
• 4.2 Infliximab and biosimilar Revenue Analysis
• 4.3 Infliximab and biosimilar Price Analysis
• 4.4 Market Concentration Degree

5 Infliximab and biosimilar Regional Market Analysis

• 5.1 Infliximab and biosimilar Production by Regions
  • 5.1.1 Global Infliximab and biosimilar Production by Regions
  • 5.1.2 Global Infliximab and biosimilar Revenue by Regions
• 5.2 Infliximab and biosimilar Consumption by Regions
• 5.3 North America Infliximab and biosimilar Market Analysis
  • 5.3.1 North America Infliximab and biosimilar Production
  • 5.3.2 North America Infliximab and biosimilar Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Infliximab and biosimilar Import and Export
• 5.4 Europe Infliximab and biosimilar Market Analysis
  • 5.4.1 Europe Infliximab and biosimilar Production
  • 5.4.2 Europe Infliximab and biosimilar Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Infliximab and biosimilar Import and Export
• 5.5 China Infliximab and biosimilar Market Analysis
  • 5.5.1 China Infliximab and biosimilar Production
  • 5.5.2 China Infliximab and biosimilar Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Infliximab and biosimilar Import and Export
• 5.6 Japan Infliximab and biosimilar Market Analysis
  • 5.6.1 Japan Infliximab and biosimilar Production
  • 5.6.2 Japan Infliximab and biosimilar Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Infliximab and biosimilar Import and Export
• 5.7 Southeast Asia Infliximab and biosimilar Market Analysis
  • 5.7.1 Southeast Asia Infliximab and biosimilar Production
  • 5.7.2 Southeast Asia Infliximab and biosimilar Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Infliximab and biosimilar Import and Export
• 5.8 India Infliximab and biosimilar Market Analysis
  • 5.8.1 India Infliximab and biosimilar Production
  • 5.8.2 India Infliximab and biosimilar Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Infliximab and biosimilar Import and Export

6 Infliximab and biosimilar Segment Market Analysis (by Type)

• 6.1 Global Infliximab and biosimilar Production by Type
• 6.2 Global Infliximab and biosimilar Revenue by Type
• 6.3 Infliximab and biosimilar Price by Type

7 Infliximab and biosimilar Segment Market Analysis (by Application)

• 7.1 Global Infliximab and biosimilar Consumption by Application
• 7.2 Global Infliximab and biosimilar Consumption Market Share by Application (2014-2019)

8 Infliximab and biosimilar Major Manufacturers Analysis

• 8.1 Janssen Biotech
  • 8.1.1 Janssen Biotech Infliximab and biosimilar Production Sites and Area Served
  • 8.1.2 Janssen Biotech Product Introduction, Application and Specification
  • 8.1.3 Janssen Biotech Infliximab and biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Merck and Co.
  • 8.2.1 Merck and Co. Infliximab and biosimilar Production Sites and Area Served
  • 8.2.2 Merck and Co. Product Introduction, Application and Specification
  • 8.2.3 Merck and Co. Infliximab and biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Pfizer
  • 8.3.1 Pfizer Infliximab and biosimilar Production Sites and Area Served
  • 8.3.2 Pfizer Product Introduction, Application and Specification
  • 8.3.3 Pfizer Infliximab and biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served

9 Development Trend of Analysis of Infliximab and biosimilar Market

• 9.1 Global Infliximab and biosimilar Market Trend Analysis
  • 9.1.1 Global Infliximab and biosimilar Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Infliximab and biosimilar Regional Market Trend
  • 9.2.1 North America Infliximab and biosimilar Forecast 2019-2025
  • 9.2.2 Europe Infliximab and biosimilar Forecast 2019-2025
  • 9.2.3 China Infliximab and biosimilar Forecast 2019-2025
  • 9.2.4 Japan Infliximab and biosimilar Forecast 2019-2025
  • 9.2.5 Southeast Asia Infliximab and biosimilar Forecast 2019-2025
  • 9.2.6 India Infliximab and biosimilar Forecast 2019-2025
• 9.3 Infliximab and biosimilar Market Trend (Product Type)
• 9.4 Infliximab and biosimilar Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Infliximab and biosimilar Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List